Evidence map›Paper›PMID 29037228›Full record

ReviewEpigenetics & chromatin2017

Neuroepigenetic mechanisms in disease.

Michael A Christopher, Stephanie M Kyle, David J Katz

Open access · goldAbstract readReview
In one paragraph

Review in Epigenetics & chromatin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Review
  3. "Advances in biomarker discovery and diagnostics for alzheimer's disease".Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Epigenetics in Alzheimer's Disease: A Critical Overview.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders.International journal of molecular sciences · 2022
    Review
  16. Article
  17. Article
  18. Mitochondrial DNA Methylation and Human Diseases.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael A ChristopherDepartment of Cell Biology, Emory University School of Medicine, 615 Michael Street, Atlanta, GA, 30322, USA.
Stephanie M KyleDepartment of Cell Biology, Emory University School of Medicine, 615 Michael Street, Atlanta, GA, 30322, USA.
David J KatzDepartment of Cell Biology, Emory University School of Medicine, 615 Michael Street, Atlanta, GA, 30322, USA. djkatz@emory.edu.ORCID 0000-0002-3040-1142
Emory University · US

Funding

The Emory Alzheimer's Disease CenterP50AG025688 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2005 to 2019
$25.7M
PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM008490 · NIGMS · EMORY UNIVERSITY · PI BOSS, JEREMY M. · 1993 to 2022
$8.0M
TRAINING IN TRANSLATIONAL RESEARCH IN NEUROLOGYT32NS007480 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2000 to 2020
$4.5M
Investigating the Role of the Histone Demethylase LSD1/KDMI in NeurodegenerationR01NS087142 · NINDS · EMORY UNIVERSITY · PI KATZ, DAVID JOHN · 2015 to 2019
$1.9M
NIA NIH HHS P50 AG025688NIGMS NIH HHS T32 GM008490NINDS NIH HHS R01 NS087142NINDS NIH HHS T32 NS007480
6 · The paper itself

Abstract

Epigenetics allows for the inheritance of information in cellular lineages during differentiation, independent of changes to the underlying genetic sequence. This raises the question of whether epigenetic mechanisms also function in post-mitotic neurons. During the long life of the neuron, fluctuations in gene expression allow the cell to pass through stages of differentiation, modulate synaptic activity in response to environmental cues, and fortify the cell through age-related neuroprotective pathways. Emerging evidence suggests that epigenetic mechanisms such as DNA methylation and histone modification permit these dynamic changes in gene expression throughout the life of a neuron. Accordingly, recent studies have revealed the vital importance of epigenetic players in the central nervous system and during neurodegeneration. Here, we provide a review of several of these recent findings, highlighting novel functions for epigenetics in the fields of Rett syndrome, Fragile X syndrome, and Alzheimer's disease research. Together, these discoveries underscore the vital importance of epigenetics in human neurological disorders.

Indexed as

Epigenesis, GeneticAlzheimer DiseaseAnimalsDNA MethylationFragile X SyndromeHistone CodeHumansRett SyndromeAlzheimer’s diseaseDNA methylationFMR1Fragile X syndromeHistone modificationLSD1/KDM1AMECP2NeuroepigeneticsRett syndrome

Identifiers

PMID29037228
PMCPMC5644115
OpenAlexW2765757299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.